Surgeons’ Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

BACKGROUND: The extent of surgery (ES) during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) is a well-known risk factor for major postoperative morbidity. Interestingly, the reliability of surgeons to predict the ES prior to CRS + HIPEC is unknown. METHODS: In th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Hentzen, Judith E. K. R., van der Plas, Willemijn Y., Been, Lukas B., Hoogwater, Frederik J. H., van Ginkel, Robert J., van Dam, Gooitzen M., Hemmer, Patrick H. J., Kruijff, Schelto
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Peritoneal Surface Malignancy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334271/
https://ncbi.nlm.nih.gov/pubmed/32052304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08237-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados